SOLICITATION NOTICE
A -- Nonclinical Services for Development of Interventional Agents for Infectious Diseases - Solicitation
- Notice Date
- 3/29/2017
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 5601 Fishers Lane, 3rd Floor, MSC 9821, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- RFP-NIAID-DMID-NIHAI2017090
- Archive Date
- 7/13/2017
- Point of Contact
- Courtney A. Markey, Phone: 3017615141, Shane Ryan, Phone: 240-669-5126
- E-Mail Address
-
courtney.markey@nih.gov, ryanes@niaid.nih.gov
(courtney.markey@nih.gov, ryanes@niaid.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The purpose of this solicitation is to support NIAID with a broad and flexible range of proactive and development oriented capabilities to provide nonclinical product development support for promising interventional agents for human infectious diseases or diseases caused by infectious agents. The Contractors shall assist NIAID Program staff in providing all support and required documentation needed for preclinical/nonclinical activities to support Investigational New Drugs (INDs), New Drug Application (NDA), or Biologic License Applications (BLAs) for advanced products. These tasks shall be conducted in accordance with quality oversight that is appropriate to the phase of the specific task and within all applicable and current Federal, state, and local laws, codes, ordinances and regulations. The purpose of this solicitation is to support NIAID with a broad and flexible range of proactive and developmentoriented capabilities to provide nonclinical product development support for promising interventional agents for human infectious diseases or diseases caused by infectious agents. The Contractors shall assist NIAID Program staff in providing all support and required documentation needed for preclinical/nonclinical activities to support Investigational New Drugs (INDs), New Drug Application (NDA), or Biologic License Applications (BLAs) for advanced products. These tasks shall be conducted in accordance with quality oversight that is appropriate to the phase of the specific task and within all applicable and current Federal, state, and local laws, codes, ordinances and regulations.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIAID/RFP-NIAID-DMID-NIHAI2017090/listing.html)
- Record
- SN04451708-W 20170331/170329235106-0fd5cd75fe5be0a2645d426baa1c70cc (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |